XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity and Stock-based Compensation Expense
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stockholders' Equity and Stock-based Compensation Expense StockholdersEquity and Stock-based Compensation Expense
The Company’s equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. In September 2021, stockholders approved an additional 450,000 shares for future grants. The 2019 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), performance stock units ("PSUs"), and other stock or cash awards.
The Company’s Board of Directors granted the Company's executive officers, senior management and certain employees 463,593 PSUs during the nine months ended September 30, 2021. Of this total, 198,591 units vest subject to the Company’s achievement of certain operational goals for the 2021 fiscal year related to product milestones, sales and commercial milestones and certain cost reduction targets. In addition, there is a service requirement related to half of the granted quantity that requires the grant recipient to provide one year of service subsequent to the milestone achievement date.

In July 2021, the Company granted 265,002 units to certain employees. This grant consists of four separate vesting quantities that will vest from April 2023 through June 2024 upon the achievement of milestones associated with each vesting quantity and continued service.
Activity under the Company's equity incentive plans is summarized as follows:
Shares
Available
for Grant
Balance, December 31, 20201,085,170 
Additional shares reserved450,000 
RSUs granted(213,522)
PSUs granted(463,593)
Options granted(172,139)
Stock awards canceled / forfeited / expired295,392 
Options canceled / forfeited / expired24,090 
Balance, September 30, 20211,005,398 

Options Outstanding
Number of
Stock Options
Outstanding
Weighted-
Average
Exercise
Price
Weighted Average Remaining Term
 (in Years)
Balance, December 31, 2020217,007 $22.35 3.75
Options granted172,139 $30.71 
Options exercised(57,498)$24.49 
Options canceled / forfeited / expired(24,090)$32.90 
Balance, September 30, 2021307,558 $25.80 4.84
Stock Awards Outstanding
Number of Awards OutstandingWeighted Average Grant Date Fair Value per Share
Balance, December 31, 2020779,757 $23.96 
RSUs granted213,522 $36.80 
PSUs granted463,593 $41.23 
Awards released(175,813)$22.45 
Stock awards canceled / forfeited / expired(298,028)$27.24 
Balance, September 30, 2021983,031 $33.91 
Stock-based Compensation Expense
Stock-based compensation expense by department recognized during the three and nine months ended September 30, 2021 and 2020 was as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021202020212020
Cost of revenue$330 $326 $908 $1,359 
Sales and marketing711 648 1,954 2,618 
Research and development1,020 254 1,628 1,344 
General and administrative1,681 754 4,017 2,736 
Total stock-based compensation expense$3,742 $1,982 $8,507 $8,057